1h Free Analyst Time
Global Neurostimulation Devices Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the neurostimulation devices market and it is poised to grow by $ 2.23 bn during 2021-2025, progressing at a CAGR of 8% during the forecast period. The report on neurostimulation devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of neurological disorders and increasing number of awareness initiatives and improvements in access to healthcare. In addition, rising prevalence of neurological disorders is anticipated to boost the growth of the market as well.
The neurostimulation devices market analysis includes product segment and geographical landscapes.
The neurostimulation devices market is segmented as below:
By Product
- Implantable neurostimulation devices
- External neurostimulation devices
By Geographical Landscapes
- North America
- Europe
- APAC
- ROW
This study identifies a rapid increase in aging population as one of the prime reasons driving the neurostimulation devices market growth during the next few years.
The report on neurostimulation devices market covers the following areas:
- Neurostimulation devices market sizing
- Neurostimulation devices market forecast
- Neurostimulation devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurostimulation devices market vendors that include Abbott Laboratories, Axonics Modulation Technologies Inc., Bioness Inc., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS INC, NeuroSigma Inc., Nexstim Plc, and Nuvectra Medical. Also, the neurostimulation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global neurostimulation devices market: Abbott Laboratories, Axonics Modulation Technologies Inc., Bioness Inc., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS INC, NeuroSigma Inc., Nexstim Plc, and Nuvectra Medical.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is a rapid increase in aging population.'
According to the report, one of the major drivers for this market is the rising prevalence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Axonics Modulation Technologies Inc.
- Bioness Inc.
- LivaNova Plc
- Medtronic Plc
- NeuroMetrix Inc.
- Neuronetics Inc
- NeuroSigma Inc.Â
- Nexstim Plc
- Nuvectra Medical